MMA
WST icon

Mizuho Markets Americas’s West Pharmaceutical WST Stock Holding History

Mizuho Markets Americas’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,011
Closed -$265K – 256
2025
Q3 		$265K Sell
1,011
-130
-11% -$31.6K 0.01% 165
2025
Q2 		$250K Sell
1,141
-2,562
-69% -$548K 0.01% 145
2025
Q1 		$829K Sell
3,703
-4,350
-54% -$1.2M 0.02% 192
2024
Q4 		$2.64M Sell
8,053
-9,367
-54% -$2.95M 0.05% 157
2024
Q3 		$5.23M Buy
17,420
+1,497
+9% +$458K 0.11% 133
2024
Q2 		$5.24M Sell
15,923
-13,705
-46% -$4.84M 0.13% 135
2024
Q1 		$11.7M Buy
29,628
+17,399
+142% +$6.44M 0.29% 58
2023
Q4 		$4.31M Buy
12,229
+3,586
+41% +$1.27M 0.12% 118
2023
Q3 		$3.24M Buy
+8,643
New +$3.34M 0.11% 82

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mizuho Markets Americas's WST Position: Q4 2025 in Review

Mizuho Markets Americas sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 1,011 shares — an estimated $265K sold.

Mizuho Markets Americas first reported a position in WST in Q3 2023 and held it in 9 quarters. The position peaked at $11.7M in Q1 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Mizuho Markets Americas reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Mizuho Markets Americas sold 1,011 West Pharmaceutical shares in Q4 2025, an estimated $265K.
  • Mizuho Markets Americas first reported a position in West Pharmaceutical in Q3 2023 and held it in 9 quarters.
  • Mizuho Markets Americas's West Pharmaceutical position peaked at $11.7M in Q1 2024.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Mizuho Markets Americas's 13F filing for Q4 2025, filed 6 Feb 2026.